October, 2017

Evolving Market Dynamics Will Continue to Influence Use of Oncology Drugs by 2019

Learn more about this key finding from our Brand Access Marketplace Dynamics for Oncology.

October, 2017

What are the largest managed care organizations?

Read this key finding from our Medicaid Rx Payers to reveal the largest managed care organizations.

October, 2017

Commercial Deficiency Due to Limited Market Access is a Growing Concern for Biopharmaceutical Companies

Read more about this key finding from our HTA Impact on Global Access research.

October, 2017

NCCN Guideline Endorsement Most Influences Decisions to Include Treatments within Pathways

Learn more about this key finding from our Oncology Pathways Insight and Evolution research.

October, 2017

How are your customers responding to the shifting political landscape?

Read about the key finding from our September Pulse of Healthcare Policy Decisions research.

October, 2017

Evolving Market Dynamics Will Continue to Influence and Limit Access to Branded Diabetes Drugs by 2019

Learn more about this key finding from our Brand Access Marketplace Dynamics research for diabetes.

October, 2017

Integrated Delivery Systems: Assessing Level of Integration

Read more about this key finding from our Health System Profiles research.

October, 2017

Payers and providers utilize multiple tactics to influence use of oncology drugs

Learn more about this key finding from our Brand Access Marketplace Dynamics research for oncology.

September, 2017

Direct Medicare Price Negotiation is Good for Payers

Learn more about this key finding from our Healthcare Policy Decisions research.

September, 2017

Which accounts have the largest LIS enrollment?

See the top 10 accounts with the largest LIS enrollment from our Managed Medicare Rx research.

Pages

Subscribe to RSS - blamb@healthstrategies.com's blog

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.